Efficient DNA interstrand crosslinking by 6-thioguanine and UVA radiation

Reto Brem, Ilse Daehn, Peter Karran

Research output: Contribution to journalArticlepeer-review

43 Scopus citations


Patients taking the immunosuppressant and anticancer thiopurines 6-mercaptopurine, azathioprine or 6-thioguanine (6-TG), develop skin cancer at a very high frequency. Their DNA contains 6-TG which absorbs ultraviolet A (UVA) radiation, and their skin is UVA hypersensitive, consistent with the formation of DNA photodamage. Here we demonstrate that UVA irradiation of 6-TG-containing DNA causes DNA interstrand crosslinking. In synthetic duplex oligodeoxynucleotides, the interstrand crosslinks (ICLs) can form between closely opposed 6-TG bases and, in a less favoured reaction, between 6-TG and normal bases on the opposite strand. In vivo, UVA irradiation of cultured cells containing 6-TG-substituted DNA also causes ICL formation and induces the chromosome aberrations that are characteristically associated with this type of DNA lesion. 6-TG/UVA activates the Fanconi anemia (FA) pathway via monoubiquitination of the FANCD2 protein. Cells defective in the FA pathway or other factors involved in ICL processing, such as XPF and DNA Polζ, are all hypersensitive to killing by 6-TG/UVA-consistent with a significant contribution of photochemical ICLs to the cytotoxicity of this treatment. Our findings suggest that sunlight-exposed skin of thiopurine treated patients may experience chronic photochemical DNA damage that requires constant intervention of the FA pathway.

Original languageEnglish
Pages (from-to)869-876
Number of pages8
JournalDNA Repair
Issue number8
StatePublished - 15 Aug 2011
Externally publishedYes


  • 6-Thioguanine
  • DNA interstrand crosslinking
  • Fanconi anemia
  • Ultraviolet A


Dive into the research topics of 'Efficient DNA interstrand crosslinking by 6-thioguanine and UVA radiation'. Together they form a unique fingerprint.

Cite this